Industry News
Pharmaceutical Industry News
The FDA has approved Jazz…
The FDA has approved Jazz Pharmaceuticals’ Zepzelca, used in combination with Roche’s Tecentriq, as a first-line maintenance treatment in extensive-stage small cell lung cancer
The initial part of the up-to-$339…
The initial part of the up-to-$339 million funding will largely be used to establish U.S. manufacturing for the non-vaccine flu preventive candidate, with additional options tied to further clinical studies, Cidara said.
GSK has successfully appealed…
GSK has successfully appealed a ruling by the U.K. marketing watchdog that determined a trio of its COVID-19 vaccine press releases had brought discredit on the pharma industry.
Sealed court documents obtained by…
Sealed court documents obtained by Fierce Biotech reveal how Novo Nordisk and Singapore's KBP Biosciences went from partners in a $1.3 billion deal to legal foes. Takeda has decided to cease all research work in
Artificial intelligence is…
Artificial intelligence is redefining industries at an unprecedented pace—and healthcare is no exception. But as algorithms grow smarter and adoption accelerates, leaders face a pressing question: how do we embrace the possibilities of AI without
Vaxcyte is paying Thermo Fisher…
Vaxcyte is paying Thermo Fisher Scientific up to $1 billion to access vaccine fill-finish capacity at the CDMO’s production facility in Greenville, North Carolina. Vaxcyte positioned the deal as a “long-term U.S. commercial manufacturing commitment.”
Chris Paquette sees data…
Chris Paquette sees data integration, personalization and cross-team alignment reshaping the industry
The FDA agreed to re-review…
The FDA agreed to re-review Vanda's previously rejected bid to market its Hetlioz in jet lag disorder, which has been the center of a years-long legal dispute between the two.
In the phase 3 Vesalius-CV study,…
In the phase 3 Vesalius-CV study, Repatha helped significantly curb the risk of major adverse cardiovascular events over standard treatment alone in people who hadn’t had a heart attack or stroke before, Amgen announced.
Vice president Michael Deichmiller…
Vice president Michael Deichmiller says trust, data and a media-first approach are reshaping the industry
Both Acadia Pharmaceuticals and…
Both Acadia Pharmaceuticals and e-therapeutics pulled back the curtain this week on new looks for their respective corporate brand identities.
Director says omnichannel…
Director says omnichannel strategies and patient-first approaches will define the future
BeOne Medicines and AbbVie have…
BeOne Medicines and AbbVie have decided to voluntarily dismiss the patent lawsuit the Big Pharma firm brought against its competitor over their BTK inhibitors.
Ansa Biotechnologies hauled in a…
Ansa Biotechnologies hauled in a total of $54.4 million in an oversubscribed series B financing round that will be used to expand the company’s DNA synthesis production capacity in the U.S.
How TrumpRx Website May Affect Your Drug Costs After Pfizer Deal
President Trump and top health officials announced a deal with Pfizer to try to lower Medicaid prices, and a website to help consumers buy drugs directly from manufacturers.
In a merger between two…
In a merger between two subcutaneous drug delivery companies, Halozyme Therapeutics is paying $750 million in cash to acquire Elektrofi.
Cancer rates are rising in young…
Cancer rates are rising in young adults. Is current care keeping up? Discover how AI and tech can bridge the gap.
In the latest instance of pharma…
In the latest instance of pharma tariff whiplash, the import duties promised by the president last week are reportedly on hold.
On The Top Line, IQVIA’s Marie…
On The Top Line, IQVIA’s Marie Flanagan explains why governance must be built into AI design from the start.
With a government shutdown now in…
With a government shutdown now in effect, the U.S. FDA—already shaken up by head count reductions earlier this year—has sought to keep many of its functions running for the foreseeable future.